Trials / Completed
CompletedNCT04768543
Stimulation Therapy for Apnea: Reporting Thoughts
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 26 (actual)
- Sponsor
- University of Pittsburgh · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Upper airway stimulation (UAS) via unilateral implantation of a phasic hypoglossal nerve stimulation device is a safe and effective alternative treatment for patients with moderate to severe obstructive sleep apnea (OSA) who are unwilling or unable to adhere to positive airway pressure (PAP) therapy. Although adherence to UAS is higher than to PAP, there remain patients who are not using UAS consistently. The aim of this project is to explore critical factors in the use of UAS by OSA patients using qualitative research methods (personal interviews). The proposed study will provide crucial information about patients' concerns regarding UAS use and suggestions for how to support new UAS recipients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Upper airway stimulation (Inspire Medical Systems, Inc.) | phasic hypoglossal nerve stimulation device |
Timeline
- Start date
- 2020-03-02
- Primary completion
- 2021-05-01
- Completion
- 2021-05-01
- First posted
- 2021-02-24
- Last updated
- 2022-08-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04768543. Inclusion in this directory is not an endorsement.